Anti-MDA5+ DM is a clinically distinct subtype of idiopathic inflammatory myopathies (IIMs), characterized by a high prevalence of rapidly progressive interstitial lung disease (RP-ILD) and poor response to conventional immunosuppressive therapies (28). The gene discussed is IFIH1; the disease is interstitial lung disease.